Byrne Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
DLA
MSV
FFA
KFP
RT
AAA
TFA
CP
VCM
Byrne Asset Management's BMY Position: Q3 2026 in Review
Byrne Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 1,819 shares worth $112K. The position accounts for 0.06% of the portfolio, ranked #217.
Byrne Asset Management first reported a position in BMY in Q4 2021 and has held it in 20 quarters since. The position peaked at $427K in Q2 2022. 129 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Byrne Asset Management held 1,819 shares of Bristol-Myers Squibb worth $112K as of Q3 2026.
- Byrne Asset Management left its Bristol-Myers Squibb share count unchanged in Q3 2026.
- Bristol-Myers Squibb made up 0.06% of Byrne Asset Management's portfolio in Q3 2026, its #217 holding.
- Byrne Asset Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 20 quarters since.
- Byrne Asset Management's Bristol-Myers Squibb position peaked at $427K in Q2 2022.
- 129 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Byrne Asset Management's 13F filing for Q3 2026, filed 6 Oct 2026.